Selective Serotonin Reuptake Inhibitor (SSRI) updated on 07-01-2025

Postpartum hemorrhage

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S18442
R78270
Lee (Controls exposed to TCAs), 2025 Postpartum haemorrhage during pregnancy (anytime or not specified) retrospective cohort (claims database) exposed to other treatment, sick excluded Adjustment: No Monotherapy: SSRI only 1.63 [1.03;2.57] C
excluded (control group)
91/1,465   24/613 115 1,465
ref
S18408
R77692
Lee (Controls unexposed, general pop), 2025 Postpartum haemorrhage during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: Yes Monotherapy: SSRI only 1.19 [0.95;1.49] 91/1,465   19,755/463,440 19,846 1,465
ref
S17719
R74736
Jackson, 2024 Post-partum hemorrhage (ICD-10 diagnosis code for PPH and a procedure code for blood transfusion) during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed, disease free Adjustment: Yes Monotherapy: SSRI only 1.59 [1.24;2.00] 84/2,106   3,047/105,000 3,131 2,106
ref
S7914
R23953
Palmsten, 2020 Postpartum haemorrhage (PPH) within 14 days after delivery during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed, sick Adjustment: No Monotherapy: SSRI only Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 1.20 [0.96;1.50] C 149/3,636   170/4,949 319 3,636
ref
S7473
R22365
Skalkidou (Controls unexposed, disease free), 2020 Postpartum haemorrhage (blood loss >1000 ml during the first 2 hours postpartum) during pregnancy (anytime or not specified) population based cohort retrospective unexposed, disease free excluded Adjustment: Yes Monotherapy: no or not specified 1.33 [1.23;1.44]
excluded (control group)
781/8,551   18,520/265,080 19,301 8,551
ref
S7829
R23243
Skalkidou (Controls unexposed, sick), 2020 Postpartum haemorrhage (blood loss >1000 ml during the first 2 hours postpartum) during pregnancy (anytime or not specified) population based cohort retrospective unexposed, sick Adjustment: No Monotherapy: no or not specified Unexposed sick: old history of illness/treatment (> 12 months before pregnancy) or not specified 1.23 [1.13;1.34] C 781/8,551   2,150/28,390 2,931 8,551
ref
S7604
R22715
Hanley, 2016 Postpartum hemorrhage late pregnancy retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: Yes Monotherapy: SSRI only 1.07 [0.97;1.18] 486/6,637   21,745/310,813 22,231 6,637
ref
S7599
R23916
Lupattelli (Controls unexposed, disease free), 2014 Postpartum hemorrhage (blood loss greater than 500 mL) late pregnancy prospective cohort unexposed, disease free excluded Adjustment: Yes Monotherapy: SSRI only 0.97 [0.57;1.65]
excluded (control group)
18/123   8,009/55,862 8,027 123
ref
S7902
R23925
Lupattelli (Controls unexposed, sick), 2014 Postpartum hemorrhage (blood loss greater than 500 mL) late pregnancy prospective cohort unexposed, sick Adjustment: No Monotherapy: SSRI only Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 0.87 [0.52;1.47] C 18/123   211/1,282 229 123
ref
S7602
R23860
Palmsten b, 2013 Postpartum hemorrhage (ICD-9 code for 666.x) late pregnancy retrospective cohort (claims database) unexposed, sick Adjustment: Yes Monotherapy: SSRI only Unexposed sick: old history of illness/treatment (> 12 months before pregnancy) or not specified 1.42 [1.27;1.57] 440/11,516   1,896/69,044 2,336 11,516
ref
S493
R15215
Colvin, 2011 Postpartum hemorrhage (>= 500 mls) during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: No Monotherapy: no or not specified 1.21 [1.09;1.35] 400/3,703   8,462/92,995 8,862 3,703
ref
S7601
R23861
Salkeld, 2008 Postpartum hemorrhage (diagnosis codes 666.10, 666.12, and 666.14 (ICD-9), codes O72002, O72004, O72102, O72104, O72109, O72202, O72204, or O72209 (ICD-10)) after vaginal or cesarean delivery 3rd trimester nested case control unexposed (general population or NOS) Adjustment: Yes Matched Monotherapy: no or not specified 1.30 [0.98;1.72] 59/501   2,401/25,902 2,460 501
ref
Total 9 studies 1.24 [1.14;1.35] 62,345 38,238
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Lee (Controls unexposed, general pop), 2025Lee, 2025 1 1.19[0.95; 1.49]19,8461,4659%ROB confusion: seriousROB selection: lowROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Jackson, 2024Jackson, 2024 1.59[1.24; 2.00]3,1312,1068%ROB confusion: moderateROB selection: lowROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Palmsten, 2020Palmsten, 2020 1.20[0.96; 1.50]3193,6369%ROB confusion: criticalROB selection: lowROB classification: criticalROB missing: unclearROB mesure: moderateROB reporting: moderate Skalkidou (Controls unexposed, sick), 2020Skalkidou, 2020 2 1.23[1.13; 1.34]2,9318,55118%ROB confusion: criticalROB selection: lowROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Hanley, 2016Hanley, 2016 1.07[0.97; 1.18]22,2316,63717%ROB confusion: moderateROB selection: lowROB classification: criticalROB missing: unclearROB mesure: moderateROB reporting: moderate Lupattelli (Controls unexposed, sick), 2014Lupattelli, 2014 3 0.87[0.52; 1.47]2291232%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Palmsten b, 2013Palmsten b, 2013 1.42[1.27; 1.57]2,33611,51616%ROB confusion: seriousROB selection: lowROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Colvin, 2011Colvin, 2011 1.21[1.09; 1.35]8,8623,70316%ROB confusion: criticalROB selection: lowROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Salkeld, 2008Salkeld, 2008 1.30[0.98; 1.72]2,4605016%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Total (9 studies) I2 = 62% 1.24[1.14; 1.35]62,34538,2380.25.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, general pop; 2: Controls unexposed, sick; 3: Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.24[1.13; 1.35]59,88537,73767%NALee (Controls unexposed, general pop), 2025 Jackson, 2024 Palmsten, 2020 Skalkidou (Controls unexposed, sick), 2020 Hanley, 2016 Lupattelli (Controls unexposed, sick), 2014 Palmsten b, 2013 Colvin, 2011 8 case control studiescase control studies 1.30[0.98; 1.72]2,460501 -NASalkeld, 2008 1 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.22[1.08; 1.38]56,53014,41262%NALee (Controls unexposed, general pop), 2025 Jackson, 2024 Hanley, 2016 Colvin, 2011 Salkeld, 2008 5 unexposed, sickunexposed, sick 1.27[1.12; 1.43]5,81523,82657%NAPalmsten, 2020 Skalkidou (Controls unexposed, sick), 2020 Lupattelli (Controls unexposed, sick), 2014 Palmsten b, 2013 4 Tags Adjustment   - No  - No 1.21[1.14; 1.29]12,34116,0130%NAPalmsten, 2020 Skalkidou (Controls unexposed, sick), 2020 Lupattelli (Controls unexposed, sick), 2014 Colvin, 2011 4   - Yes  - Yes 1.29[1.10; 1.52]50,00422,22579%NALee (Controls unexposed, general pop), 2025 Jackson, 2024 Hanley, 2016 Palmsten b, 2013 Salkeld, 2008 5 MatchedMatched 1.30[0.98; 1.72]2,460501 -NASalkeld, 2008 1 Monotherapy   - no or not specified  - no or not specified 1.22[1.15; 1.31]14,25312,7550%NASkalkidou (Controls unexposed, sick), 2020 Colvin, 2011 Salkeld, 2008 3   - SSRI only  - SSRI only 1.24[1.07; 1.45]48,09225,48376%NALee (Controls unexposed, general pop), 2025 Jackson, 2024 Palmsten, 2020 Hanley, 2016 Lupattelli (Controls unexposed, sick), 2014 Palmsten b, 2013 6 Unexposed sick   - old history of illness/treatment (> ...  - old history of illness/treatment (> 12 months before pregnancy) or not specified 1.32[1.14; 1.52]5,26720,06777%NASkalkidou (Controls unexposed, sick), 2020 Palmsten b, 2013 2   - recent illness/treatment (during o ...  - recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 1.12[0.86; 1.45]5483,75919%NAPalmsten, 2020 Lupattelli (Controls unexposed, sick), 2014 2 All studiesAll studies 1.24[1.14; 1.35]62,34538,23862%NALee (Controls unexposed, general pop), 2025 Jackson, 2024 Palmsten, 2020 Skalkidou (Controls unexposed, sick), 2020 Hanley, 2016 Lupattelli (Controls unexposed, sick), 2014 Palmsten b, 2013 Colvin, 2011 Salkeld, 2008 90.25.01.0

Publication bias and p-hacking diagnosis

funnel plot
0.0-0.60.80.3190.000Lee (Controls unexposed, general pop), 2025Jackson, 2024Palmsten, 2020Skalkidou (Controls unexposed, sick), 2020Hanley, 2016Lupattelli (Controls unexposed, sick), 2014Palmsten b, 2013Colvin, 2011Salkeld, 2008

Asymetry test p-value = 0.8784 (by Egger's regression)

slope=0.1930 (0.0886); intercept=0.2034 (1.2820); t=0.1587; p=0.8784

p values plot
0.01.00.01.0

Sub-groups analysis using all included studies

excluded 7599, 7473, 18442

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.24[1.12; 1.37]83,85823,08665%NALee (Controls unexposed, general pop), 2025 Jackson, 2024 Skalkidou (Controls unexposed, disease free), 2020 Hanley, 2016 Lupattelli (Controls unexposed, disease free), 2014 Colvin, 2011 Salkeld, 2008 7 unexposed, sick controlsunexposed, sick controls 1.27[1.12; 1.43]5,81523,82657%NAPalmsten, 2020 Skalkidou (Controls unexposed, sick), 2020 Lupattelli (Controls unexposed, sick), 2014 Palmsten b, 2013 4 exposed to other treatment, sick controlsexposed to other treatment, sick controls 1.63[1.03; 2.57]1151,465 -NALee (Controls exposed to TCAs), 2025 10.510.01.0

Umbrella review (other published meta-analyses)

Published MAControlPeriodTE95% CIn exposedkI2 Jiang - SSRI (Postpartum hemorrhage)Jiang - SSRI (Postpartum hemorrhage) 1.20[1.04; 1.38]86%-Wwhatever (meta-analysis)Anyduring pregnancy (anytime or not specified)studies TTT5 metaPregmetaPreg 1.24[1.14; 1.35]62%38,238----Lee (Controls unexposed, general pop), 2025 Jackson, 2024 Palmsten, 2020 Skalkidou (Controls unexposed, sick), 2020 Hanley, 2016 Lupattelli (Controls unexposed, sick), 2014 Palmsten b, 2013 Colvin, 2011 Salkeld, 2008 90.510.01.0